Low Dose(1mcg) ACTH Stimulation Test for Assessment of the Hypothalamus-pituitary-adrenal Axis in Patients Treated With Inhaled Busedonide or Fluticasone.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Adrenal Insufficiency
- Sponsor
- HaEmek Medical Center, Israel
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- stimulated serum cortisol levels
- Status
- Terminated
- Last Updated
- 9 years ago
Overview
Brief Summary
Inhaled corticosteroids are largely used in patients with asthma or chronic obstructive lung diseases. The purpose of this study is to determine if the use of inhaled corticosteroids is associated with suppression of endogenous cortisol production, as seen in patients treated with pharmacologic doses of oral or parenteral steroids.
Detailed Description
The normalcy of the hypothalmic-pituitary-adrenal (HPA) axis of enrolled subjects will be assessed by low dose (1mcg) corticotropin (ACTH)stimulation test. Serum cortisol levels will be measured before , 30 minutes and 60 minutes after 1 mcg ACTH intravenous injection.
Investigators
Eligibility Criteria
Inclusion Criteria
- •patients receiving inhaled busedonide or fluticasone at daily dose of 200-800 mcg ' for at least 4 weeks
Exclusion Criteria
- •patients receiving any corticosteroid therapy, except inhaled busedonide or fluticasone.
Outcomes
Primary Outcomes
stimulated serum cortisol levels
Time Frame: within 30 days of treatment